How to measure vaccine harms

Drug harm reporting systems, like the MHRA’s yellow card system, are designed to alert the regulator to a potential issue. They are not designed to measure the size of the problem. If an issue is highlighted then the regulator has a responsibility to carry out an audit and see whether the incidence of the condition of concern has been higher than historical levels in the population who were vaccinated.

Read More

Vaccine Damage: the human cost of rushed-to-market products

The existing mechanism for compensating those suffering vaccine damage was set up in 1979. If the vaccination caused ‘severe disablement’ (classed, somewhat callously, as being ‘60% disabled’), then one can become eligible for a one-off payment of £120,000, but only if you are able to undergo an excruciating and protracted battle with the authorities to have your claim accepted.

Read More

Children’s covid vaccines: it’s all about balance of risks…

Over many months, a group of experienced health professionals and academics have been writing to the MHRA and the JCVI regarding the vaccination of healthy children, with most of the letters posted on the HART website. In our most recent letter, the authors have called for a pause to the children’s vaccine rollout pending a thorough investigation of a number of safety concerns. 

Read More

Open Letter from the Children’s Covid Vaccines Advisory Group (CCVAG) to the JCVI: Pause vaccines for children pending urgent review

We wrote to you and also the MHRA last month regarding urgent investigation of the acknowledged increase in all cause mortality in males aged 15-19 since the Pfizer covid vaccine rollout commenced in this age group in May 2021. ONS have acknowledged in the High Court in London, that the figure of 402 excess deaths is significantly higher than the previous 5 year average of 337 deaths. Indeed they stated it is probably an underestimate because of delays for coroners’ cases. This equates to at least one additional teenage boy dying each week. It is thus very disappointing not to have received any response.

Read More

Covid-19 vaccines are “Safe & Effective” and have had all the usual testing ??

This may be the strap line of MHRA but is not the view of HART member Dr John Flack, retired Director of Safety Evaluation at Beecham Pharmaceuticals and subsequent Senior Vice-president for Drug Discovery at SmithKline Beecham. Wisdom is a rarity in today’s world, but this article is overflowing with sage words about the workings of the pharmaceutical industry. It’s a pity SAGE doesn’t reflect the same meaning.

Read More